www.ushifu.com

US HIFU, LLC is a privately held healthcare company focused on treating primary and recurrent prostate cancer using HIFU, a minimally invasive outpatient procedure. US HIFU was founded in 2004 and is headquartered in Charlotte, N.C.

The Sonablate^® 500 is a minimally invasive medical device that utilizes ultrasound energy to destroy tissue within the body. It was developed by Focus Surgery, Inc. and is manufactured by Misonix, Inc. (NASDAQ: MSON) who also holds distribution rights in Europe. Takai Hospital Supply Ltd. and THS International distribute the Sonablate^® 500 in Southeast Asia and the Middle East. The Sonablate^® 500 is not approved for use in the U.S. The Sonablate^® 500 remains investigational in the U.S. and is being studied for the treatment of prostate cancer in clinical trials in the U.S. FDA has made no decision as to the safety or efficacy of the Sonablate^® 500 for the treatment of prostate cancer.

Press release:

 US HIFU LLC secures $5 Million FInancing from MMV Financial